PHARMA TEST C200 Pharmacom

£48.00

PHARMA TEST C200 Pharmacom is a pharmaceutical-grade testosterone cypionate formulation containing 200mg/ml designed for advanced endocrinological and hormone research studies in controlled laboratory environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
PHARMA TEST C200 Pharmacom
PHARMA TEST C200 Pharmacom
£48.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Research Overview of PHARMA TEST C200

PHARMA TEST C200 Pharmacom is a pharmaceutical-grade testosterone cypionate injectable formulation containing 200mg/ml of active compound. Testosterone cypionate is a long-acting synthetic androgen and anabolic steroid extensively studied in endocrinological research. This compound represents the cypionate ester variant of endogenous testosterone, designed to provide sustained hormone release profiles in experimental models. The formulation is manufactured to pharmaceutical standards by Pharmacom Labs, ensuring consistent concentration and purity for reliable research outcomes. Researchers investigating androgenic mechanisms, hormone replacement protocols, and endocrine system modulation frequently utilise testosterone cypionate as a reference standard. The injectable oil-based preparation allows for precise dosing control in laboratory studies examining testosterone pharmacokinetics and tissue-specific effects across various research applications.

Laboratory Research Applications

Scientists examine testosterone cypionate in numerous research domains including endocrinology, sports science, and reproductive biology studies. The compound serves as a valuable tool for investigating androgen receptor binding affinity, protein synthesis pathways, and muscle tissue development mechanisms in cell culture and animal models. Researchers study the cypionate ester’s extended half-life properties to understand sustained hormone delivery systems. Stroid UK Shop provides this formulation for studies examining hypogonadism models, aging-related hormone decline, and therapeutic intervention protocols. Laboratory investigations often focus on the compound’s effects on nitrogen retention, bone density markers, and lipid metabolism parameters. Testosterone research compounds like PHARMA TEST C200 enable scientists to analyse dose-response relationships and tissue-specific androgenic activity patterns.

Technical Specifications

PHARMA TEST C200 Pharmacom Research Specifications
Parameter Value
Active Substance Testosterone Cypionate
Concentration 200mg/ml
Manufacturer Pharmacom Labs
Formulation Injectable Oil Solution
CAS Number 58-20-8
Molecular Formula C₂₇H₄₀O₃
Molecular Weight 412.6 g/mol
Storage Requirements Room Temperature, Protected from Light

This pharmaceutical preparation undergoes rigorous quality control testing to ensure batch-to-batch consistency essential for reproducible research results. SARMs research often involves comparative studies with traditional androgens like testosterone cypionate. Peptide research frequently examines interactions between hormone therapies and growth factor pathways.

Research Compliance Statement

PHARMA TEST C200 Pharmacom is intended exclusively for in-vitro laboratory research and analytical testing purposes. This product is not approved for human consumption, therapeutic use, or any application outside controlled scientific environments. Researchers must possess appropriate licensing and facilities for handling controlled substances. All investigations should follow institutional guidelines and regulatory requirements for research chemical handling. This compound is supplied solely for academic research, pharmaceutical development, and analytical reference standard applications under proper laboratory supervision.

Related